Literature DB >> 7924825

Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes.

A Muir1, D Schatz, N Maclaren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7924825     DOI： 10.1002/dmr.5610090408

Source DB:  PubMed          Journal:  Diabetes Metab Rev        ISSN： 0742-4221


× No keyword cloud information.
  8 in total

1.  Peptide-based treatment for autoimmune diseases: learning how to handle a double-edged sword.

Authors:  Alberto Pugliese
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity.

Authors:  S Garg; V Bal; S Rath; A George
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Increased frequency of IgM antibodies to cow's milk proteins in Hungarian children with newly diagnosed insulin-dependent diabetes mellitus.

Authors:  T Saukkonen; E Savilahti; L Madácsy; A Arató; A Körner; L Barkai; A Sarnesto; H K Akerblom
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

4.  Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes.

Authors:  L C Harrison; M Dempsey-Collier; D R Kramer; K Takahashi
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

5.  Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.

Authors:  T Bárdos; M Czipri; C Vermes; J Zhang; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 6.  Prediction and prevention of type 1 diabetes.

Authors:  A E Morales; J X She; D A Schatz
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

7.  Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.

Authors:  A Muir; A Peck; M Clare-Salzler; Y H Song; J Cornelius; R Luchetta; J Krischer; N Maclaren
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

8.  Long-term outcome of individuals treated with oral insulin: diabetes prevention trial-type 1 (DPT-1) oral insulin trial.

Authors:  Kendra Vehik; David Cuthbertson; Holly Ruhlig; Desmond A Schatz; Mark Peakman; Jeffrey P Krischer
Journal:  Diabetes Care       Date:  2011-05-24       Impact factor: 19.112
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.